<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?origin publisher?><?properties no_embargo?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Immunogenetics</journal-id><journal-title>Immunogenetics</journal-title><issn pub-type="ppub">0093-7711</issn><issn pub-type="epub">1432-1211</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17333166</article-id><article-id pub-id-type="publisher-id">199</article-id><article-id pub-id-type="doi">10.1007/s00251-007-0199-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>The <italic>SPINK</italic> gene family and celiac disease susceptibility</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wapenaar</surname><given-names>Martin C.</given-names></name><address><phone>+31-50-3617123</phone><fax>+31-50-3617230</fax><email>m.c.wapenaar@medgen.umcg.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Monsuur</surname><given-names>Alienke J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Poell</surname><given-names>Jos</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>van &#x02018;t Slot</surname><given-names>Ruben</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meijer</surname><given-names>Jos W. R.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meijer</surname><given-names>Gerrit A.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mulder</surname><given-names>Chris J.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mearin</surname><given-names>Maria Luisa</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wijmenga</surname><given-names>Cisca</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Complex Genetics Section, DBG-Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands </aff><aff id="Aff2"><label>2</label>Department of Genetics, University Medical Center Groningen, P.O. Box 30 001, 9700 RB Groningen, The Netherlands </aff><aff id="Aff3"><label>3</label>Department of Pathology, Rijnstate Hospital, Arnhem, The Netherlands </aff><aff id="Aff4"><label>4</label>Department of Pathology, VU Medical Center, Amsterdam, The Netherlands </aff><aff id="Aff5"><label>5</label>Department of Gastroenterology, VU Medical Center, Amsterdam, The Netherlands </aff><aff id="Aff6"><label>6</label>Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>2</month><year>2007</year></pub-date><pub-date pub-type="ppub"><month>5</month><year>2007</year></pub-date><volume>59</volume><issue>5</issue><fpage>349</fpage><lpage>357</lpage><history><date date-type="received"><day>7</day><month>6</month><year>2006</year></date><date date-type="accepted"><day>19</day><month>1</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9; Springer-Verlag 2007</copyright-statement></permissions><abstract><p>The gene family of serine protease inhibitors of the Kazal type (<italic>SPINK</italic>) are functional and positional candidate genes for celiac disease (CD). Our aim was to assess the gut mucosal gene expression and genetic association of <italic>SPINK1</italic>, -<italic>2</italic>, -<italic>4</italic>, and -<italic>5</italic> in the Dutch CD population. Gene expression was determined for all four <italic>SPINK</italic> genes by quantitative reverse-transcription polymerase chain reaction in duodenal biopsy samples from untreated (<italic>n</italic>&#x02009;=&#x02009;15) and diet-treated patients (<italic>n</italic>&#x02009;=&#x02009;31) and controls (<italic>n</italic>&#x02009;=&#x02009;16). Genetic association of the four <italic>SPINK</italic> genes was tested within a total of 18 haplotype tagging SNPs, one coding SNP, 310 patients, and 180 controls. The <italic>SPINK4</italic> study cohort was further expanded to include 479 CD cases and 540 controls. <italic>SPINK4</italic> DNA sequence analysis was performed on six members of a multigeneration CD family to detect possible point mutations or deletions. <italic>SPINK4</italic> showed differential gene expression, which was at its highest in untreated patients and dropped sharply upon commencement of a gluten-free diet. Genetic association tests for all four <italic>SPINK</italic> genes were negative, including <italic>SPINK4</italic> in the extended case/control cohort. No <italic>SPINK4</italic> mutations or deletions were observed in the multigeneration CD family with linkage to chromosome 9p21-13 nor was the coding SNP disease-specific. <italic>SPINK4</italic> exhibits CD pathology-related differential gene expression, likely derived from altered goblet cell activity. All of the four <italic>SPINK</italic> genes tested do not contribute to the genetic risk for CD in the Dutch population.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1007/s00251-007-0199-5) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group><title>Keywords</title><kwd><italic>SPINK</italic> genes</kwd><kwd>Celiac disease</kwd><kwd>Quantitative reverse-transcription polymerase chain reaction</kwd><kwd>Genetic association</kwd></kwd-group><custom-meta-wrap><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2007</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Celiac disease (CD) is a chronic inflammatory condition of the small intestine because of an immunological intolerance for the food protein gluten. Patients have to adhere to a life-long diet devoid of gluten to prevent the detrimental effects of a prolonged nutrient and mineral deficiency (Green and Jabri <xref ref-type="bibr" rid="CR10">2003</xref>). Susceptibility for CD is predominantly determined by genetic factors, and the complex inheritance patterns suggest the interaction of multiple genes (van Heel et al. <xref ref-type="bibr" rid="CR35">2005</xref>). It is well established that the adaptive immune response to gluten plays a pivotal role in the pathogenesis of CD. Th1 activation of CD4<sup>+</sup> T cells follows gluten-peptide presentation by DQ2 or DQ8 molecules expressed on antigen-presenting cells (Sollid <xref ref-type="bibr" rid="CR30">2002</xref>). The <italic>HLA-DQA</italic> and -<italic>DQB</italic> gene variants coding for these molecules are the major genetic determinants for CD susceptibility (Koning et al. <xref ref-type="bibr" rid="CR16">2005</xref>). Recently, the importance of innate immunity in CD pathogenesis was also underscored by the observation of induced IL15 expression and NKT cell chemotaxis through the MICA and NKG2D molecules (Hue et al. <xref ref-type="bibr" rid="CR13">2004</xref>; Meresse et al. <xref ref-type="bibr" rid="CR20">2004</xref>). However, no genetic contribution of the cognate genes has been demonstrated. The notion of crosstalk between the adaptive and innate immune systems is not limited to CD and gets much attention in studies of the inflammatory process (Hoebe et al. <xref ref-type="bibr" rid="CR12">2004</xref>). This raises the question whether some aspects of innate immunity may contribute to the genetic susceptibility for CD. The innate immune system uses a wide array of defense mechanisms against the invasion of pathogens. These encompass the expression of pattern recognition receptors, release of antimicrobial molecules, and preservation of epithelial barrier and tissue integrity by, e.g., serine protease inhibitors (Kimbrell and Beutler <xref ref-type="bibr" rid="CR15">2001</xref>).</p><p>One branch of the family of serine protease inhibitors is that of the Kazal type (<italic>SPINK</italic>) that originally consisted of four members in humans (<italic>SPINK1</italic>, <italic>SPINK2</italic>, <italic>SPINK4</italic>, and <italic>SPINK5</italic>). Recently, as part of a cluster of <italic>SPINK</italic> genes on chromosome 5q32 that already included <italic>SPINK1</italic> and <italic>SPINK5</italic>, five new <italic>SPINK</italic>(-like) members were identified that were located more distally: <italic>SPINK5L2</italic>, <italic>SPINK6</italic>, <italic>SPINK5L3</italic>, <italic>SPINK7</italic>, and <italic>SPINK9</italic>, respectively (NCBI Map Viewer, build 36.1). However, these new members lack functional annotation and were therefore not included in this study. <italic>SPINK</italic> family members 1, 2, and 4 have a comparable size and structure coded for by 4 exons with a single Kazal type serine protease inhibitor domain. <italic>SPINK5</italic>, in contrast, contains 33 exons that encode 15 inhibitory domains. All four <italic>SPINK</italic> members are thought to be involved in the protection against proteolytic degradation of epithelial and mucosal tissues, although their major site of expression may differ. <italic>SPINK1</italic> is expressed in the pancreas and the gastrointestinal tract, and mutations in this gene are reported in various forms of pancreatitis (Pfutzer and Whitcomb <xref ref-type="bibr" rid="CR25">2001</xref>). <italic>SPINK2</italic> (located on 4q12) is expressed in the testis, epididymis, and seminal vesicle, where its antimicrobial function may be involved in protection of fertility (Rockett et al. <xref ref-type="bibr" rid="CR26">2004</xref>). <italic>SPINK4</italic> was originally isolated from pig intestine (Agerberth et al. <xref ref-type="bibr" rid="CR1">1989</xref>) and is abundantly expressed in human and porcine goblet cells in the crypts of Lieberk&#x000fc;hn but was also found in monocytes and in the central nervous system (Metsis et al. <xref ref-type="bibr" rid="CR21">1992</xref>; Norberg et al. <xref ref-type="bibr" rid="CR23">2003</xref>). <italic>SPINK5</italic> is expressed in the thymus, vaginal epithelium, Bartolin&#x02019;s glands, oral mucosa, tonsils, and the parathyroid glands (Magert et al. <xref ref-type="bibr" rid="CR19">1999</xref>). Mutations in <italic>SPINK5</italic> are responsible for the Netherton syndrome, a lethal skin disorder characterized by ichthyosis, hair shaft defects, atopy, skin barrier defects, and recurrent bacterial infections (Bitoun et al. <xref ref-type="bibr" rid="CR4">2002</xref>). Mouse models of the Netherton syndrome have shown enhanced proteolysis of desmoglein 1 and filaggrin in <italic>SPINK5</italic> mutants (Descargues et al. <xref ref-type="bibr" rid="CR7">2005</xref>; Hewett et al. <xref ref-type="bibr" rid="CR11">2005</xref>). Moreover, <italic>SPINK5</italic> has also been associated with asthma and atopic dermatitis (Blumenthal <xref ref-type="bibr" rid="CR5">2005</xref>).</p><p>Interestingly, both <italic>SPINK1</italic> and <italic>SPINK5</italic> are located on chromosome 5q32. This region contains the CELIAC2 susceptibility locus that emerged repeatedly in linkage studies (Babron et al. <xref ref-type="bibr" rid="CR2">2003</xref>). Despite the fact that this region is rich in candidate cytokine genes and intense mapping efforts were made, no closely associated genes were identified (Ryan et al. <xref ref-type="bibr" rid="CR28">2005</xref>). Likewise, <italic>SPINK4</italic> is located on chromosome 9p13.3 and resides within a linkage region (9p21-13) where we previously identified a novel CD locus that segregated within a four-generation Dutch family (van Belzen et al. <xref ref-type="bibr" rid="CR34">2004</xref>). Taken together, the role of <italic>SPINK</italic> genes in epithelial and mucosal protection and the important genetic locations of <italic>SPINK1</italic>, <italic>SPINK4</italic>, and <italic>SPINK5</italic> prompted us to subject the four conventional members of the <italic>SPINK</italic> family to gene expression and genetic association analyses to ascertain their possible role in CD pathogenesis.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Patient material</title><p>Duodenal biopsy samples were collected by endoscopy as part of a routine CD diagnostic procedure or to monitor the response to a gluten-free diet in previously diagnosed patients. All patients were classified using the Marsh nomenclature according to the UEGW criteria (Report of a working group of the United European Gastroenterology Week in Amsterdam <xref ref-type="bibr" rid="CR27">2001</xref>). Two biopsy samples taken in parallel to those used for histological examination were pooled and used for determination of gene expression. In total, 62 individuals were examined with quantitative reverse transcription polymerase chain reaction (qRT-PCR), of which 16 were normal controls, and 46 were CD patients (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). The patient group consisted of 15 untreated cases with villous atrophy (MIII) and 31 patients treated with a gluten-free diet who were in various stages of mucosal recovery: MII (crypt hyperplasia; <italic>n</italic>&#x02009;=&#x02009;11), MI (lymphocyte infiltration; <italic>n</italic>&#x02009;=&#x02009;8), and M0 (complete remission; <italic>n</italic>&#x02009;=&#x02009;12). The biopsies of all participating patients were reevaluated by an experienced pathologist, and only CD patients with a proven original Marsh III lesion were included in this study. The genetic association study on all four <italic>SPINK</italic> genes was initially conducted on a cohort of 310 independent CD patients and 180 independent age- and sex-matched controls, all of which were from Dutch Caucasian decent. In a second stage, exclusively focused on all <italic>SPINK4</italic> SNPs, we added 360 controls to a total of 540. In case of three <italic>SPINK4</italic> variants with suggestive <italic>P</italic> values, the power of the study was further enhanced by adding 169 extra CD cases to a total of 479. In parallel, we also examined the <italic>SPINK4</italic> gene in a previously described four-generation Dutch CD family (van Belzen et al. <xref ref-type="bibr" rid="CR34">2004</xref>). Six family members and a CEPH control were subjected to DNA sequence analysis of the <italic>SPINK4</italic> coding regions and splice sites boundaries. Additionally, we performed <italic>SPINK4</italic> SNP haplotype analysis in this family. All patients and family members that volunteered for this study signed an informed consent. The study was approved by the Medical Ethics Committee of the University Medical Center Utrecht. <fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Results of qRT-PCR of <italic>SPINK</italic> genes in normal controls (<italic>NC</italic>) and CD patients, either untreated (<italic>MIII</italic>) or on a gluten-free diet (<italic>MII</italic>&#x02013;<italic>M0</italic>). The Marsh stages refer to the pathological conditions of the mucosa, characterized by atrophy of the villi (<italic>MIII</italic>); hyperplastic crypts between the villi (<italic>MIII</italic>&#x02013;<italic>MII</italic>); and enhanced lymphocyte infiltration (<italic>MIII</italic>&#x02013;<italic>MII</italic>&#x02013;<italic>MI</italic>). Stage <italic>M0</italic> indicates complete remission comparable to controls. The genes tested were as follows: <italic>SPINK1</italic> (<bold>a</bold>); <italic>SPINK2</italic> (<bold>b</bold>); <italic>SPINK4</italic> (<bold>c</bold>); and <italic>SPINK5</italic> (<bold>d</bold>). Measurements were made in triplicate, on pools of separately prepared cDNA samples. Expression data were normalized to the normal control pool.(<bold>e</bold>) Relative expression of all four <italic>SPINK</italic> genes with respect to <italic>SPINK2</italic> in the healthy duodenal mucosa. Note the logarithmic scale here. The <italic>GUSB</italic> gene was used as an endogenous control in all tests. <italic>Error</italic><italic>bars</italic> indicate standard deviations</p></caption><graphic position="anchor" xlink:href="251_2007_199_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec4"><title>Expression study</title><p>The isolation of total RNA from biopsy samples and the analysis of gene expression by real-time qRT-PCR on an ABI Prism 7900HT was performed as described before (Wapenaar et al. <xref ref-type="bibr" rid="CR36">2004</xref>). We used the commercially available Assay-on-Demand test for <italic>SPINK1</italic> (Hs00162154_m1), <italic>SPINK2</italic> (Hs00221653_m1), <italic>SPINK4</italic> (Hs00205508_m1), <italic>SPINK5</italic> (Hs00199260), and the endogenous control gene GUSB (PDAR 4326320E; Applied Biosystems, Foster City, CA). All samples were tested in triplicate on pooled cDNA samples representing each Marsh class. The results were confirmed with cDNA from individual samples tested in duplicate. Relative levels of gene expression were obtained using the SDS2.1 software (Applied Biosystems).</p></sec><sec id="Sec5"><title>Genetic association and data analysis</title><p>Haplotype tagging SNPs were selected for <italic>SPINK1</italic>, <italic>SPINK2</italic>, <italic>SPINK4</italic>, and <italic>SPINK5</italic> based on HapMap (Phase I) data using Haploview (Barrett et al. <xref ref-type="bibr" rid="CR3">2005</xref>). For each haploblock containing SNPs in high linkage disequilibrium, one or more representative SNPs were selected that should capture the genetic variation within that block. For the four <italic>SPINK</italic> genes tested, this resulted in a set of 18 haplotype tagging SNPs and one coding SNP (see Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). SNP assays were obtained from Applied Biosystems and analyzed on an ABI Prism 7900HT. Hardy&#x02013;Weinberg Equilibrium (HWE) was evaluated separately in cases and controls for all SNPs tested. Allele frequencies were compared between cases and controls, and <italic>P</italic> values were obtained by <italic>&#x003c7;</italic><sup>2</sup> analysis. <table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Allelic distribution of <italic>SPINK</italic> haplotype tagging SNPs in a Dutch CD case-control cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4">&#x000a0;</th><th colspan="4">Cases (<italic>n</italic>&#x02009;=&#x02009;310)</th><th colspan="4">Controls (<italic>n</italic>&#x02009;=&#x02009;180)</th><th rowspan="2" colspan="2">&#x000a0;</th></tr><tr><th colspan="3">&#x000a0;</th><th>Allele</th><th colspan="2">Allele counts</th><th colspan="2">Allele frequency (%)</th><th colspan="2">Allele counts</th><th colspan="2">Allele frequency (%)</th></tr><tr><th>Gene name</th><th>SNP i.d.</th><th>Position*</th><th>Minor/major</th><th>Minor</th><th>Major</th><th>Minor</th><th>Major</th><th>Minor</th><th>Major</th><th>Minor</th><th>Major</th><th><italic>&#x003c7;</italic><sup>2</sup></th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td><italic>SPINK1</italic></td><td>rs10515593</td><td>147,178,993</td><td>A/G</td><td>119</td><td>449</td><td>21</td><td>79</td><td>76</td><td>268</td><td>22.1</td><td>77.9</td><td>0.166</td><td>0.6834</td></tr><tr><td><italic>SPINK1</italic></td><td>rs3777125</td><td>147,184,010</td><td>C/G</td><td>228</td><td>336</td><td>40.4</td><td>59.6</td><td>150</td><td>200</td><td>42.9</td><td>57.1</td><td>0.527</td><td>0.4681</td></tr><tr><td><italic>SPINK1</italic></td><td>rs4705204</td><td>147,195,313</td><td>C/A</td><td>125</td><td>429</td><td>22.6</td><td>77.4</td><td>60</td><td>276</td><td>17.9</td><td>82.1</td><td>2.813</td><td>0.0935</td></tr><tr><td><italic>SPINK1</italic></td><td>rs891992</td><td>147,205,707</td><td>G/A</td><td>77</td><td>483</td><td>13.8</td><td>86.2</td><td>47</td><td>303</td><td>13.4</td><td>86.6</td><td>0.019</td><td>0.8906</td></tr><tr><td><italic>SPINK2</italic></td><td>rs10015630</td><td>57,520,070</td><td>A/G</td><td>216</td><td>328</td><td>39.7</td><td>60.3</td><td>136</td><td>216</td><td>38.6</td><td>61.4</td><td>0.102</td><td>0.7489</td></tr><tr><td><italic>SPINK2</italic></td><td>rs781542</td><td>57,528,232</td><td>G/A</td><td>220</td><td>390</td><td>36.1</td><td>63.9</td><td>123</td><td>221</td><td>35.8</td><td>64.2</td><td>0.009</td><td>0.9237</td></tr><tr><td><italic>SPINK4</italic></td><td>rs563353</td><td>33,206,428</td><td>G/C</td><td>120</td><td>472</td><td>20.3</td><td>79.7</td><td>67</td><td>279</td><td>19.4</td><td>80.6</td><td>0.112</td><td>0.7375</td></tr><tr><td><italic>SPINK4</italic></td><td>rs563512</td><td>33,206,484</td><td>G/A</td><td>50</td><td>556</td><td>8.3</td><td>91.7</td><td>36</td><td>310</td><td>10.4</td><td>89.6</td><td>1.243</td><td>0.2648</td></tr><tr><td><italic>SPINK4</italic></td><td>rs891671</td><td>33,222,271</td><td>G/T</td><td>70</td><td>540</td><td>11.5</td><td>88.5</td><td>52</td><td>304</td><td>14.6</td><td>85.4</td><td>1.998</td><td>0.1575</td></tr><tr><td><italic>SPINK4</italic></td><td>rs706107**</td><td>33,230,225</td><td>A/G</td><td>117</td><td>499</td><td>19</td><td>81</td><td>81</td><td>269</td><td>23.1</td><td>76.9</td><td>2.358</td><td>0.1246</td></tr><tr><td><italic>SPINK4</italic></td><td>rs706109</td><td>33,230,668</td><td>A/G</td><td>118</td><td>486</td><td>19.5</td><td>80.5</td><td>82</td><td>276</td><td>22.9</td><td>77.1</td><td>1.549</td><td>0.2133</td></tr><tr><td><italic>SPINK4</italic></td><td>rs706115</td><td>33,243,605</td><td>G/C</td><td>77</td><td>537</td><td>12.5</td><td>87.5</td><td>52</td><td>308</td><td>14.4</td><td>85.6</td><td>0.716</td><td>0.3975</td></tr><tr><td><italic>SPINK5</italic></td><td>rs3756688</td><td>147,422,972</td><td>G/A</td><td>232</td><td>380</td><td>37.9</td><td>62.1</td><td>135</td><td>221</td><td>37.9</td><td>62.1</td><td>0.000</td><td>0.9968</td></tr><tr><td><italic>SPINK5</italic></td><td>rs4472254</td><td>147,433,830</td><td>A/C</td><td>240</td><td>376</td><td>39</td><td>61</td><td>142</td><td>214</td><td>39.9</td><td>60.1</td><td>0.081</td><td>0.7757</td></tr><tr><td><italic>SPINK5</italic></td><td>rs4519913</td><td>147,452,004</td><td>G/A</td><td>279</td><td>331</td><td>45.7</td><td>54.3</td><td>168</td><td>192</td><td>46.7</td><td>53.3</td><td>0.079</td><td>0.7792</td></tr><tr><td><italic>SPINK5</italic></td><td>rs1422987</td><td>147,466,552</td><td>T/C</td><td>49</td><td>559</td><td>8.1</td><td>91.9</td><td>27</td><td>329</td><td>7.6</td><td>92.4</td><td>0.070</td><td>0.7917</td></tr><tr><td><italic>SPINK5</italic></td><td>rs3815740</td><td>147,471,386</td><td>G/A</td><td>38</td><td>574</td><td>6.2</td><td>93.8</td><td>21</td><td>337</td><td>5.9</td><td>94.1</td><td>0.047</td><td>0.8291</td></tr><tr><td><italic>SPINK5</italic></td><td>rs2052532</td><td>147,476,500</td><td>G/A</td><td>200</td><td>414</td><td>32.6</td><td>67.4</td><td>117</td><td>241</td><td>32.7</td><td>67.3</td><td>0.001</td><td>0.9723</td></tr><tr><td><italic>SPINK5</italic></td><td>rs3764930</td><td>147,485,309</td><td>G/A</td><td>199</td><td>413</td><td>32.5</td><td>67.5</td><td>117</td><td>243</td><td>32.5</td><td>67.5</td><td>0.000</td><td>0.9958</td></tr></tbody></table><table-wrap-foot><p>*Basepair position according to NCBI build 35.1</p><p>**Coding SNP, nonsynonymous change (Val7Ile)</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Genomic organization of the four <italic>SPINK</italic> genes. The <italic>upper</italic><italic>horizontal</italic><italic>line</italic> indicates exon locations (<italic>vertical</italic><italic>bars</italic>) and SNP positions (<italic>numbered</italic><italic>asterisks</italic>). The SNPs are numbered for each gene consecutively as they appear in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. <italic>SPINK4</italic> SNP no. <italic>4</italic> represents the nonsynonymous (Val7Ile) coding SNP rs706107. The <italic>arrow</italic><italic>points</italic> indicate the orientation of transcription. The <italic>lower</italic><italic>portion</italic> of the figure shows the pairwise linkage-disequilibrium structure between indicated SNPs given by <italic>D</italic>&#x02032; statistics based on the European population in the HapMap database (Phase II). <italic>Darker</italic><italic>red</italic> intensities indicate higher <italic>D</italic>&#x02032; values (<italic>numbers</italic> indicate D&#x02019; value, whereas SNP pairs without number have a <italic>D</italic>&#x02032;&#x02009;=&#x02009;1)</p></caption><graphic position="anchor" xlink:href="251_2007_199_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec6"><title>DNA sequence analysis</title><p>DNA sequence analysis was performed on <italic>SPINK4</italic> in six members of a four-generation Dutch CD family and one CEPH control (family, 1,331; individual, 2). Of these six family members, four were affected (index 02, 08, 32, and 41) and carried the disease-linked haplotype, and two were nonaffected (index 21 and 31) without this haplotype (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). All coding sequences of the <italic>SPINK4</italic> gene were PCR-amplified, including the intron&#x02013;exon boundaries (for primers and protocols, see supplementary data Table&#x000a0;<xref ref-type="" rid="MOESM2">1</xref>). PCR products were examined on a 2% agarose gel and purified with a Millipore Vacuum Manifold (Billerica, MA). Samples were prepared with the BigDye terminator cycle sequencing ready kit (Applied Biosystems) according to the manufacturer&#x02019;s protocol. PCR and sequencing amplification were performed on a GeneAmp PCR system 9700 (Perkin Elmer, Foster City, CA). Sequences were run on an ABI Prism 3730 analyzer (Applied Biosystems). Analysis and sequence alignment was carried out with Sequence Navigator (Applied Biosystems) and Vector NTI (InforMax, Massachusetts) software packages. <fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Pedigree of the Dutch multigeneration CD family. Only affected descendents are depicted (10 out of 13 siblings in the second generation were affected). The grandparental <italic>SPINK4</italic> haplotypes that are <italic>boxed</italic> and <italic>shaded</italic> are identical to the grandmaternal at-risk haplotype (noninformative). The SNPs are ordered (<italic>top</italic>-<italic>to</italic>-<italic>bottom</italic>) as they appear in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. Genotype numbers <italic>1</italic>, <italic>2</italic>, <italic>3</italic>, and <italic>4</italic> refer to A, C, G, and T alleles, respectively. Sequence analysis was performed on family members <italic>02</italic>, <italic>08</italic>, <italic>21</italic>, <italic>31</italic>, <italic>32</italic>, and <italic>41</italic>. Family member index numbers are indicated in <italic>bold</italic></p></caption><graphic position="anchor" xlink:href="251_2007_199_Fig3_HTML" id="MO3"/></fig></p></sec></sec><sec id="Sec7" sec-type="results"><title>Results</title><sec id="Sec8"><title><italic>SPINK</italic> gene expression in the CD mucosa</title><p>The expression of all four conventional members of the human <italic>SPINK</italic> family was determined by real-time qRT-PCR on duodenal biopsy-derived cDNA pools from normal controls and CD patients, either untreated or in various stages of remission on a gluten-free diet. The results shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> indicate that only <italic>SPINK4</italic> (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c) is differentially expressed, and that its transcriptional activity, which is at its highest in Marsh III (20-fold compared to controls), decreases sharply (fourfold) when patients improve and make a transition to Marsh II. To preclude that the results for <italic>SPINK4</italic> might be biased by fortuitous differences in individual expression levels within the generated pools, we also examined the control and case samples each separately. This did not change the observed drop in <italic>SPINK4</italic> expression during tissue recovery (see supplementary Fig.&#x000a0;<xref ref-type="" rid="MOESM1">1</xref>). Likewise, we performed the same analysis for the other three <italic>SPINK</italic> genes without affecting the profile already observed in the pools (results not shown). We also examined the relative expression of the four <italic>SPINK</italic> genes with respect to each other in the normal intestinal mucosa. This showed that both <italic>SPINK1</italic> and <italic>SPINK4</italic> have the highest expression, which is respectively 480-fold and 240-fold higher compared to <italic>SPINK2</italic>, whereas <italic>SPINK5</italic> is in the same order of magnitude (fivefold) as <italic>SPINK2</italic> (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>e). In conclusion, only the <italic>SPINK4</italic> gene appears to be differentially regulated in the intestinal mucosa during recovery from the gluten-evoked CD lesion. This observation prompted us to examine whether <italic>SPINK4</italic>, or any of the other <italic>SPINK</italic> genes, could also be causally related to the CD pathogenesis.</p></sec><sec id="Sec9"><title>Genetic association analysis of <italic>SPINK</italic> genes</title><p>We designed a haplotype tagging SNP strategy to capture all genetic variation in <italic>SPINK1</italic>, -<italic>2</italic>, -<italic>4</italic>, and -<italic>5</italic>. An overview of these four <italic>SPINK</italic> genes with their genomic organization, linkage-disequilibrium structure, and the position of the haplotype tagging SNPs used is depicted in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>. Initially, these haplotype tagging SNPs were tested in 310&#x000a0;CD cases and 180 controls (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) and showed no significant association for any of the haplotype tagging SNPs in the four SPINK genes. Despite the initial negative result, we decided to pursue <italic>SPINK4</italic> further because it is expressed in goblet cells (Metsis et al. <xref ref-type="bibr" rid="CR21">1992</xref>), displayed a CD pathology-related differential expression in the intestinal mucosa, and mapped within a CD linkage region (van Belzen et al. <xref ref-type="bibr" rid="CR34">2004</xref>). Initially, we expanded the control group with 360 samples to a total of 540 for all <italic>SPINK4</italic> SNPs tested. As a result, the Val7Ile coding variant rs706107 and its flanking haplotype tagging SNPs rs891671 and rs706109 yielded suggestive but nonsignificant <italic>P</italic> values of 0.0595, 0.0510, and 0.1122, respectively (data not shown). To increase the power of the study even further, we subsequently added 169&#x000a0;CD cases to a total of 479. The effect on the <italic>P</italic> values of the three SNPs tested was such that they dropped below the significance threshold (see Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). From this, we conclude that the four <italic>SPINK</italic> genes tested do not contribute to the genetic susceptibility in the Dutch CD population. <table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Allelic distribution of three selected <italic>SPINK4</italic> SNPs in the extended Dutch CD case-control cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4">&#x000a0;</th><th colspan="4">Cases (<italic>n</italic>&#x02009;=&#x02009;479)</th><th colspan="4">Controls (<italic>n</italic>&#x02009;=&#x02009;540)</th><th rowspan="2" colspan="2">&#x000a0;</th></tr><tr><th colspan="3">&#x000a0;</th><th>Allele</th><th colspan="2">Allele counts</th><th colspan="2">Allele frequency (%)</th><th colspan="2">Allele counts</th><th colspan="2">Allele frequency (%)</th></tr><tr><th>Gene name</th><th>SNP i.d.</th><th>Position*</th><th>Minor/major</th><th>Minor</th><th>Major</th><th>Minor</th><th>Major</th><th>Minor</th><th>Major</th><th>Minor</th><th>Major</th><th><italic>&#x003c7;</italic><sup>2</sup></th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td><italic>SPINK4</italic></td><td>rs891671</td><td>33,222,271</td><td>G/T</td><td>126</td><td>814</td><td>13.4</td><td>86.6</td><td>158</td><td>904</td><td>14.9</td><td>85.1</td><td>0.889</td><td>0.3457</td></tr><tr><td><italic>SPINK4</italic></td><td>rs706107**</td><td>33,230,225</td><td>A/G</td><td>205</td><td>737</td><td>21.8</td><td>78.2</td><td>242</td><td>814</td><td>22.9</td><td>77.1</td><td>0.382</td><td>0.5365</td></tr><tr><td><italic>SPINK4</italic></td><td>rs706109</td><td>33,230,668</td><td>A/G</td><td>212</td><td>724</td><td>22.6</td><td>77.4</td><td>242</td><td>816</td><td>22.9</td><td>77.1</td><td>0.014</td><td>0.9053</td></tr></tbody></table><table-wrap-foot><p>*Basepair position according to NCBI build 35.1</p><p>**Coding SNP, nonsynonymous change (Val7Ile)</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title><italic>SPINK4</italic> sequence analysis in a multigeneration family</title><p>We have previously described a four-generation CD family with an extraordinary high incidence of affected individuals (see Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). The disease segregated with a grandmaternal haplotype on chromosome 9p21-13 (van Belzen et al. <xref ref-type="bibr" rid="CR34">2004</xref>), a region that encompasses <italic>SPINK4</italic>. The apparent dominant inheritance pattern could be caused by a mutation that is rare in the general CD population but present with a high phenotypic penetration in this specific family. To assess if any functional variants of the <italic>SPINK4</italic> gene were present in this family, we sequenced all its exons and intron&#x02013;exon boundaries in six family members. However, we did not observe mutations in any of the samples tested (results not shown). Neither was the exon 1 coding SNP rs706107 specific for affected individuals as all seven individuals tested (including the CEPH control) carried the most frequent GG genotype (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). To exclude the possibility of deletions in <italic>SPINK4</italic> to be misinterpreted from the sequence data as homozygous genotypes, we also performed segregation analysis of the grandparental <italic>SPINK4</italic> haplotypes within the entire family but observed no suspect inheritance pattern (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). In conclusion, we have found no evidence that <italic>SPINK4</italic> is a candidate gene for the chromosome 9p21-13 CD locus in the Dutch population in general or in the multigeneration Dutch CD family specifically.</p></sec></sec><sec id="Sec11" sec-type="discussion"><title>Discussion</title><p>Chronic inflammatory conditions and autoimmune disorders are typically characterized by a deregulated adaptive and innate immune system. The innate defense consists of multiple components that include physical barriers, antimicrobial molecules, pattern recognition receptors, circulating phagocytes, and the complement system (Hoebe et al. <xref ref-type="bibr" rid="CR12">2004</xref>). A breach of the epithelial barrier and loss of microbial containment is often the first of a series of events that trigger or sustain chronic inflammatory diseases (Tlaskalova-Hogenova et al. <xref ref-type="bibr" rid="CR31">2004</xref>) as described, e.g., in Crohn&#x02019;s disease, atopic eczema, asthma, and psoriasis (Schreiber et al. <xref ref-type="bibr" rid="CR29">2005</xref>). In CD, the gut&#x02013;lumen separation is undermined by dietary gluten that evokes a combined innate and adaptive immune response (Londei et al. <xref ref-type="bibr" rid="CR18">2005</xref>). It is the joined action of gluten peptides, environmental factors, and genetic determinants that precipitates this enteropathy. The human leukocyte antigen locus is the major genetic contribution to the adaptive Th1 reaction (Koning et al. <xref ref-type="bibr" rid="CR16">2005</xref>). Recently, we identified <italic>MYO9B</italic> as a susceptibility gene in the Dutch population that possibly has an effect on epithelial barrier integrity (Monsuur et al. <xref ref-type="bibr" rid="CR22">2005</xref>). Several other studies have underscored the involvement of innate immunity in CD, however, without identification of underlying causative gene variants (Londei et al. <xref ref-type="bibr" rid="CR18">2005</xref>). Interestingly, it was also reported that the epithelial glycocalyx and the bacterial composition in the CD gut is distinct (Forsberg et al. <xref ref-type="bibr" rid="CR8">2004</xref>; Tjellstrom et al. <xref ref-type="bibr" rid="CR32">2005</xref>).</p><p>In search of genes that may have a primary contribution to CD pathogenesis, we focused our attention to the <italic>SPINK</italic> family of serine protease inhibitors that play an important role in tissue preservation through the containment of uncontrolled proteolysis and bacterial growth. In this study, we demonstrated differential gene expression of mucosal <italic>SPINK4</italic> in CD. Crypt hyperplasia is a feature of the Marsh III and Marsh II stages of CD, and the concomitant increase in the number of goblet cells may contribute to the increased <italic>SPINK4</italic> expression. However, the observed sharp decrease in gene expression sets in during the MIII/MII transition, whereas crypt normalization is observed only later at the MII/MI recovery phase. This suggests that <italic>SPINK4</italic> downregulation sets in soon after commencement of the gluten-free diet. This <italic>SPINK4</italic> differential expression probably reflects altered goblet cell activity, but its functional significance and regulatory mechanism in CD pathology remains to be established.</p><p>The combination of functional relevance and mapping to CD linkage intervals pointed to the <italic>SPINK</italic> family members as attractive functional and positional candidate genes. We have chosen a robust strategy for genetic association testing based on haplotype tagging SNPs and linkage-disequilibrium structure of the <italic>SPINK</italic> loci applied to a considerably sized Dutch case-control cohort. With our study design, we had 75% power to confirm association with <italic>SPINK1</italic>, -<italic>2</italic>, and -<italic>5</italic> (relative risk 2.0; allele frequency 0.1&#x02013;0.45; 95% confidence interval), whereas this was even 95% (RR 2.0) and 80% (RR 1.6) for <italic>SPINK4</italic>. These power estimates reflect a Type I error rate of 0.05, which is appropriate for testing a previously reported result. Initial detection of a new genetic association would require much more stringent criteria to assure reproducibility, and power would be correspondingly less.</p><p>In parallel, we examined the extended Dutch CD family for variants and deletions in <italic>SPINK4</italic>. We hypothesized that a specific <italic>SPINK4</italic> mutation, although rare in the general population, could have a dramatic impact on mucus composition, bacterial containment, and gluten sensitivity, thereby explaining the apparent dominant and high penetration inheritance pattern in our extended CD family. With both approaches, we were not able to establish a genetic involvement of the <italic>SPINK</italic> genes tested. However, we cannot completely rule out the possibility of a rare noncoding mutation in <italic>SPINK4</italic> (outside the splice donor and acceptor regions) that might specifically segregate in this atypical CD family, characterized by an exceptional high prevalence of affected members.</p><p>Despite this negative result in the Dutch CD population, we cannot formally rule out the possibility of genetic contribution of <italic>SPINK</italic> genes to CD in other European populations like the Italian in whom, unlike the Dutch (van Belzen et al. <xref ref-type="bibr" rid="CR33">2003</xref>), chromosome 5q linkage was established (Greco et al. <xref ref-type="bibr" rid="CR9">1998</xref>; Percopo et al. <xref ref-type="bibr" rid="CR24">2003</xref>). Genuine population heterogeneity has been reported before, e.g., between <italic>CARD15</italic>/<italic>NOD2</italic> and Crohn&#x02019;s disease (Lesage et al. <xref ref-type="bibr" rid="CR17">2002</xref>; Croucher et al. <xref ref-type="bibr" rid="CR6">2003</xref>) and between <italic>SPINK5</italic> and asthma (Blumenthal <xref ref-type="bibr" rid="CR5">2005</xref>; Jongepier et al. <xref ref-type="bibr" rid="CR14">2005</xref>). The new <italic>SPINK</italic> members on chromosome 5q (<italic>SPINK5L2</italic>, <italic>SPINK6</italic>, <italic>SPINK5L3</italic>, <italic>SPINK7</italic>, and <italic>SPINK9</italic>) were not part of this study. Currently, no functional annotation is available for these genes that are located near <italic>SPINK1</italic> and <italic>SPINK5</italic> in a chromosomal region that appears to have been subjected to gene duplication during evolution. Therefore, we cannot exclude their possible involvement in CD or any other inflammatory disorder.</p></sec><sec sec-type="supplementary-material"><title>Electronic Supplementary Material</title><supplementary-material id="N0x1c30a00N0x2d0b870" content-type="local-data"><p>Below is the link to the electronic supplementary material. </p><media id="MOESM1" xlink:href="251_2007_199_MOESM1_ESM.gif"><label>Supplementary Fig.&#x000a0;S1</label><caption><p>(GIF 14.0&#x000a0;kb)</p></caption></media><media xlink:href="251_2007_199_MOESM2_ESM.pdf" id="MOESM2" mimetype="application" mime-subtype="pdf"><label>Supplementary Table&#x000a0;1</label><caption><p>Primers and reaction conditions used for <italic>SPINK4</italic> DNA sequence analysis. (PDF 80.0&#x000a0;KB)</p></caption></media></supplementary-material></sec></body><back><ack><title>Acknowledgment</title><p>We wish to thank the Dutch celiac disease patients and their family for participating in this study. We like to thank Dr. Joachim Schweizer (LUMC) for biopsy sampling. This study was supported by grants from the Dutch Digestive Diseases Foundation (MLDS, WS00-13) and The Netherlands Organization for Scientific Research (ZonMW, 912-02-028). This research was carried out within the Celiac Disease Consortium, an innovative cluster approved by The Netherlands Genomics Initiative and partially funded by a Dutch government grant (BSIK03009).</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Agerberth</surname><given-names>B</given-names></name><name><surname>Soderling-Barros</surname><given-names>J</given-names></name><name><surname>Jornvall</surname><given-names>H</given-names></name><etal/></person-group><article-title>Isolation and characterization of a 60-residue intestinal peptide structurally related to the pancreatic secretory type of trypsin inhibitor: influence on insulin secretion</article-title><source>Proc Natl Acad Sci USA</source><year>1989</year><volume>86</volume><fpage>8590</fpage><lpage>8594</lpage><pub-id pub-id-type="doi">10.1073/pnas.86.21.8590</pub-id></citation><citation citation-type="display-unstructured">Agerberth B, Soderling-Barros J, Jornvall H et al (1989) Isolation and characterization of a 60-residue intestinal peptide structurally related to the pancreatic secretory type of trypsin inhibitor: influence on insulin secretion. Proc Natl Acad Sci USA 86:8590&#x02013;8594 <pub-id pub-id-type="pmid">2573065</pub-id></citation></ref><ref id="CR2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Babron</surname><given-names>MC</given-names></name><name><surname>Nilsson</surname><given-names>S</given-names></name><name><surname>Adamovic</surname><given-names>S</given-names></name><etal/></person-group><article-title>Meta and pooled analysis of European coeliac disease data</article-title><source>Eur J Hum Genet</source><year>2003</year><volume>11</volume><fpage>828</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1038/sj.ejhg.5201051</pub-id></citation><citation citation-type="display-unstructured">Babron MC, Nilsson S, Adamovic S et al (2003) Meta and pooled analysis of European coeliac disease data. Eur J Hum Genet 11:828&#x02013;834 <pub-id pub-id-type="pmid">14571266</pub-id></citation></ref><ref id="CR3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><etal/></person-group><article-title>Haploview: analysis and visualization of LD and haplotype maps</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><fpage>263</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bth457</pub-id></citation><citation citation-type="display-unstructured">Barrett JC, Fry B, Maller J et al (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263&#x02013;265 <pub-id pub-id-type="pmid">15297300</pub-id></citation></ref><ref id="CR4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bitoun</surname><given-names>E</given-names></name><name><surname>Chavanas</surname><given-names>S</given-names></name><name><surname>Irvine</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families</article-title><source>J Invest Dermatol</source><year>2002</year><volume>118</volume><fpage>352</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1747.2002.01603.x</pub-id></citation><citation citation-type="display-unstructured">Bitoun E, Chavanas S, Irvine AD et al (2002) Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 118:352&#x02013;361 <pub-id pub-id-type="pmid">11841556</pub-id></citation></ref><ref id="CR5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blumenthal</surname><given-names>MN</given-names></name></person-group><article-title>The role of genetics in the development of asthma and atopy</article-title><source>Curr Opin Allergy Clin Immunol</source><year>2005</year><volume>5</volume><fpage>141</fpage><lpage>145</lpage></citation><citation citation-type="display-unstructured">Blumenthal MN (2005) The role of genetics in the development of asthma and atopy. Curr Opin Allergy Clin Immunol 5:141&#x02013;145 <pub-id pub-id-type="pmid">15764904</pub-id></citation></ref><ref id="CR27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Catassi</surname><given-names>C</given-names></name><name><surname>Cellier</surname><given-names>C</given-names></name><name><surname>Cerf-Bensussan</surname><given-names>N</given-names></name><name><surname>Ciclitira</surname><given-names>PJ</given-names></name><name><surname>Collin</surname><given-names>P</given-names></name><name><surname>Corazza</surname><given-names>GR</given-names></name><name><surname>Dickey</surname><given-names>W</given-names></name><name><surname>Fasano</surname><given-names>A</given-names></name><name><surname>Holmes</surname><given-names>GKT</given-names></name><name><surname>Klincewicz</surname><given-names>P</given-names></name><name><surname>Mearin</surname><given-names>ML</given-names></name><name><surname>Mulder</surname><given-names>CJJ</given-names></name><name><surname>Murray</surname><given-names>JA</given-names></name><name><surname>Pena</surname><given-names>AS</given-names></name><name><surname>Schuppan</surname><given-names>D</given-names></name><name><surname>Sollid</surname><given-names>LM</given-names></name><name><surname>Uil</surname><given-names>JJ</given-names></name><name><surname>Wahab</surname><given-names>PJ</given-names></name><name><surname>Walker-Smith</surname><given-names>JA</given-names></name><name><surname>Watson</surname><given-names>P</given-names></name><name><surname>Belzen</surname><given-names>M</given-names></name><name><surname>Blomberg</surname><given-names>BME</given-names></name><name><surname>Bouquet</surname><given-names>J</given-names></name><name><surname>Bijleveldt</surname><given-names>CMA</given-names></name><name><surname>Crusius</surname><given-names>JBA</given-names></name><name><surname>Douwes</surname><given-names>AC</given-names></name><name><surname>George</surname><given-names>EK</given-names></name><name><surname>Hamer</surname><given-names>RJ</given-names></name><name><surname>Janssen</surname><given-names>FW</given-names></name><name><surname>Meyer</surname><given-names>JWR</given-names></name><name><surname>Sinaasappel</surname><given-names>M</given-names></name><name><surname>Rostami</surname><given-names>K</given-names></name><name><surname>Taminiau</surname><given-names>JAJM</given-names></name><name><surname>Vader</surname><given-names>LW</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name></person-group><article-title>When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam</article-title><source>Eur J Gastroenterol Hepatol</source><year>2001</year><volume>13</volume><fpage>1123</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1097/00042737-200109000-00023</pub-id></citation><citation citation-type="display-unstructured">Catassi C, Cellier C, Cerf-Bensussan N, Ciclitira PJ, Collin P, Corazza GR, Dickey W, Fasano A, Holmes GKT, Klincewicz P, Mearin ML, Mulder CJJ, Murray JA, Pena AS, Schuppan D, Sollid LM, Uil JJ, Wahab PJ, Walker-Smith JA, Watson P, Van Belzen M, Von Blomberg BME, Bouquet J, Bijleveldt CMA, Crusius JBA, Douwes AC, George EK, Hamer RJ, Janssen FW, Meyer JWR, Sinaasappel M, Rostami K, Taminiau JAJM, Vader LW, Wijmenga C (2001) When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam. Eur J Gastroenterol Hepatol 13: 1123&#x02013;1128 <pub-id pub-id-type="pmid">11564968</pub-id></citation></ref><ref id="CR6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Croucher</surname><given-names>PJ</given-names></name><name><surname>Mascheretti</surname><given-names>S</given-names></name><name><surname>Hampe</surname><given-names>J</given-names></name><etal/></person-group><article-title>Haplotype structure and association to Crohn&#x02019;s disease of CARD15 mutations in two ethnically divergent populations</article-title><source>Eur J Hum Genet</source><year>2003</year><volume>11</volume><fpage>6</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1038/sj.ejhg.5200897</pub-id></citation><citation citation-type="display-unstructured">Croucher PJ, Mascheretti S, Hampe J et al (2003) Haplotype structure and association to Crohn&#x02019;s disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 11:6&#x02013;16 <pub-id pub-id-type="pmid">12529700</pub-id></citation></ref><ref id="CR7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Descargues</surname><given-names>P</given-names></name><name><surname>Deraison</surname><given-names>C</given-names></name><name><surname>Bonnart</surname><given-names>C</given-names></name><etal/></person-group><article-title><italic>Spink5</italic>-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity</article-title><source>Nat Genet</source><year>2005</year><volume>37</volume><fpage>56</fpage><lpage>65</lpage></citation><citation citation-type="display-unstructured">Descargues P, Deraison C, Bonnart C et al (2005) Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 37:56&#x02013;65 <pub-id pub-id-type="pmid">15619623</pub-id></citation></ref><ref id="CR8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forsberg</surname><given-names>G</given-names></name><name><surname>Fahlgren</surname><given-names>A</given-names></name><name><surname>Horstedt</surname><given-names>P</given-names></name><etal/></person-group><article-title>Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease</article-title><source>Am J Gastroenterol</source><year>2004</year><volume>99</volume><fpage>894</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2004.04157.x</pub-id></citation><citation citation-type="display-unstructured">Forsberg G, Fahlgren A, Horstedt P et al (2004) Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol 99:894&#x02013;904 <pub-id pub-id-type="pmid">15128357</pub-id></citation></ref><ref id="CR9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greco</surname><given-names>L</given-names></name><name><surname>Corazza</surname><given-names>G</given-names></name><name><surname>Babron</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Genome search in celiac disease</article-title><source>Am J Hum Genet</source><year>1998</year><volume>62</volume><fpage>669</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1086/301754</pub-id></citation><citation citation-type="display-unstructured">Greco L, Corazza G, Babron MC et al (1998) Genome search in celiac disease. Am J Hum Genet 62:669&#x02013;675 <pub-id pub-id-type="pmid">9497251</pub-id></citation></ref><ref id="CR10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>PH</given-names></name><name><surname>Jabri</surname><given-names>B</given-names></name></person-group><article-title>Coeliac disease</article-title><source>Lancet</source><year>2003</year><volume>362</volume><fpage>383</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(03)14027-5</pub-id></citation><citation citation-type="display-unstructured">Green PH, Jabri B (2003) Coeliac disease. Lancet 362:383&#x02013;391 <pub-id pub-id-type="pmid">12907013</pub-id></citation></ref><ref id="CR11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hewett</surname><given-names>DR</given-names></name><name><surname>Simons</surname><given-names>AL</given-names></name><name><surname>Mangan</surname><given-names>NE</given-names></name><etal/></person-group><article-title>Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>335</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddi030</pub-id></citation><citation citation-type="display-unstructured">Hewett DR, Simons AL, Mangan NE et al (2005) Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome. Hum Mol Genet 14:335&#x02013;346 <pub-id pub-id-type="pmid">15590704</pub-id></citation></ref><ref id="CR12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoebe</surname><given-names>K</given-names></name><name><surname>Janssen</surname><given-names>E</given-names></name><name><surname>Beutler</surname><given-names>B</given-names></name></person-group><article-title>The interface between innate and adaptive immunity</article-title><source>Nat Immunol</source><year>2004</year><volume>5</volume><fpage>971</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1038/ni1004-971</pub-id></citation><citation citation-type="display-unstructured">Hoebe K, Janssen E, Beutler B (2004) The interface between innate and adaptive immunity. Nat Immunol 5:971&#x02013;974 <pub-id pub-id-type="pmid">15454919</pub-id></citation></ref><ref id="CR13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hue</surname><given-names>S</given-names></name><name><surname>Mention</surname><given-names>JJ</given-names></name><name><surname>Monteiro</surname><given-names>RC</given-names></name><etal/></person-group><article-title>A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease</article-title><source>Immunity</source><year>2004</year><volume>21</volume><fpage>367</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.06.018</pub-id></citation><citation citation-type="display-unstructured">Hue S, Mention JJ, Monteiro RC et al (2004) A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21:367&#x02013;377 <pub-id pub-id-type="pmid">15357948</pub-id></citation></ref><ref id="CR14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jongepier</surname><given-names>H</given-names></name><name><surname>Koppelman</surname><given-names>GH</given-names></name><name><surname>Nolte</surname><given-names>IM</given-names></name><etal/></person-group><article-title>Polymorphisms in SPINK5 are not associated with asthma in a Dutch population</article-title><source>J Allergy Clin Immunol</source><year>2005</year><volume>115</volume><fpage>486</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2004.12.013</pub-id></citation><citation citation-type="display-unstructured">Jongepier H, Koppelman GH, Nolte IM et al (2005) Polymorphisms in SPINK5 are not associated with asthma in a Dutch population. J Allergy Clin Immunol 115:486&#x02013;492 <pub-id pub-id-type="pmid">15753894</pub-id></citation></ref><ref id="CR15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimbrell</surname><given-names>DA</given-names></name><name><surname>Beutler</surname><given-names>B</given-names></name></person-group><article-title>The evolution and genetics of innate immunity</article-title><source>Nat Rev Genet</source><year>2001</year><volume>2</volume><fpage>256</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1038/35066006</pub-id></citation><citation citation-type="display-unstructured">Kimbrell DA, Beutler B (2001) The evolution and genetics of innate immunity. Nat Rev Genet 2:256&#x02013;267 <pub-id pub-id-type="pmid">11283698</pub-id></citation></ref><ref id="CR16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koning</surname><given-names>F</given-names></name><name><surname>Schuppan</surname><given-names>D</given-names></name><name><surname>Cerf-Bensussan</surname><given-names>N</given-names></name><etal/></person-group><article-title>Pathomechanisms in celiac disease</article-title><source>Best Pract Res Clin Gastroenterol</source><year>2005</year><volume>19</volume><fpage>373</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1016/j.bpg.2005.02.003</pub-id></citation><citation citation-type="display-unstructured">Koning F, Schuppan D, Cerf-Bensussan N et al (2005) Pathomechanisms in celiac disease. Best Pract Res Clin Gastroenterol 19:373&#x02013;387 <pub-id pub-id-type="pmid">15925843</pub-id></citation></ref><ref id="CR17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lesage</surname><given-names>S</given-names></name><name><surname>Zouali</surname><given-names>H</given-names></name><name><surname>Cezard</surname><given-names>JP</given-names></name><etal/></person-group><article-title>CARD15/NOD2 mutational analysis and genotype&#x02013;phenotype correlation in 612 patients with inflammatory bowel disease</article-title><source>Am J Hum Genet</source><year>2002</year><volume>70</volume><fpage>845</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1086/339432</pub-id></citation><citation citation-type="display-unstructured">Lesage S, Zouali H, Cezard JP et al (2002) CARD15/NOD2 mutational analysis and genotype&#x02013;phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:845&#x02013;857 <pub-id pub-id-type="pmid">11875755</pub-id></citation></ref><ref id="CR18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Londei</surname><given-names>M</given-names></name><name><surname>Ciacci</surname><given-names>C</given-names></name><name><surname>Ricciardelli</surname><given-names>I</given-names></name><etal/></person-group><article-title>Gliadin as a stimulator of innate responses in celiac disease</article-title><source>Mol Immunol</source><year>2005</year><volume>42</volume><fpage>913</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2004.12.005</pub-id></citation><citation citation-type="display-unstructured">Londei M, Ciacci C, Ricciardelli I et al (2005) Gliadin as a stimulator of innate responses in celiac disease. Mol Immunol 42:913&#x02013;918 <pub-id pub-id-type="pmid">15829281</pub-id></citation></ref><ref id="CR19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magert</surname><given-names>HJ</given-names></name><name><surname>Standker</surname><given-names>L</given-names></name><name><surname>Kreutzmann</surname><given-names>P</given-names></name><etal/></person-group><article-title>LEKTI, a novel 15-domain type of human serine proteinase inhibitor</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>21499</fpage><lpage>21502</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.31.21499</pub-id></citation><citation citation-type="display-unstructured">Magert HJ, Standker L, Kreutzmann P et al (1999) LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem 274:21499&#x02013;21502 <pub-id pub-id-type="pmid">10419450</pub-id></citation></ref><ref id="CR20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meresse</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Ciszewski</surname><given-names>C</given-names></name><etal/></person-group><article-title>Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease</article-title><source>Immunity</source><year>2004</year><volume>21</volume><fpage>357</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2004.06.020</pub-id></citation><citation citation-type="display-unstructured">Meresse B, Chen Z, Ciszewski C et al (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21:357&#x02013;366 <pub-id pub-id-type="pmid">15357947</pub-id></citation></ref><ref id="CR21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metsis</surname><given-names>M</given-names></name><name><surname>Cintra</surname><given-names>A</given-names></name><name><surname>Solfrini</surname><given-names>V</given-names></name><etal/></person-group><article-title>Molecular cloning of PEC-60 and expression of its mRNA and peptide in the gastrointestinal tract and immune system</article-title><source>J Biol Chem</source><year>1992</year><volume>267</volume><fpage>19829</fpage><lpage>19832</lpage></citation><citation citation-type="display-unstructured">Metsis M, Cintra A, Solfrini V et al (1992) Molecular cloning of PEC-60 and expression of its mRNA and peptide in the gastrointestinal tract and immune system. J Biol Chem 267:19829&#x02013;19832 <pub-id pub-id-type="pmid">1400298</pub-id></citation></ref><ref id="CR22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monsuur</surname><given-names>AJ</given-names></name><name><surname>Bakker</surname><given-names>PI</given-names></name><name><surname>Alizadeh</surname><given-names>BZ</given-names></name><etal/></person-group><article-title>Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect</article-title><source>Nat Genet</source><year>2005</year><volume>37</volume><fpage>1341</fpage><lpage>1344</lpage><pub-id pub-id-type="doi">10.1038/ng1680</pub-id></citation><citation citation-type="display-unstructured">Monsuur AJ, de Bakker PI, Alizadeh BZ et al (2005) Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 37:1341&#x02013;1344 <pub-id pub-id-type="pmid">16282976</pub-id></citation></ref><ref id="CR23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norberg</surname><given-names>A</given-names></name><name><surname>Gruber</surname><given-names>S</given-names></name><name><surname>Angelucci</surname><given-names>F</given-names></name><etal/></person-group><article-title>Identification of the bioactive peptide PEC-60 in brain</article-title><source>Cell Mol Life Sci</source><year>2003</year><volume>60</volume><fpage>378</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1007/s000180300030</pub-id></citation><citation citation-type="display-unstructured">Norberg A, Gruber S, Angelucci F et al (2003) Identification of the bioactive peptide PEC-60 in brain. Cell Mol Life Sci 60:378&#x02013;381 <pub-id pub-id-type="pmid">12678500</pub-id></citation></ref><ref id="CR24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Percopo</surname><given-names>S</given-names></name><name><surname>Babron</surname><given-names>MC</given-names></name><name><surname>Whalen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Saturation of the 5q31-q33 candidate region for coeliac disease</article-title><source>Ann Hum Genet</source><year>2003</year><volume>67</volume><fpage>265</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1046/j.1469-1809.2003.00026.x</pub-id></citation><citation citation-type="display-unstructured">Percopo S, Babron MC, Whalen M et al (2003) Saturation of the 5q31-q33 candidate region for coeliac disease. Ann Hum Genet 67:265&#x02013;268 <pub-id pub-id-type="pmid">12914578</pub-id></citation></ref><ref id="CR25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pfutzer</surname><given-names>RH</given-names></name><name><surname>Whitcomb</surname><given-names>DC</given-names></name></person-group><article-title>SPINK1 mutations are associated with multiple phenotypes</article-title><source>Pancreatology</source><year>2001</year><volume>1</volume><fpage>457</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1159/000055847</pub-id></citation><citation citation-type="display-unstructured">Pfutzer RH, Whitcomb DC (2001) SPINK1 mutations are associated with multiple phenotypes. Pancreatology 1:457&#x02013;460 <pub-id pub-id-type="pmid">12120224</pub-id></citation></ref><ref id="CR26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rockett</surname><given-names>JC</given-names></name><name><surname>Patrizio</surname><given-names>P</given-names></name><name><surname>Schmid</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Gene expression patterns associated with infertility in humans and rodent models</article-title><source>Mutat Res</source><year>2004</year><volume>549</volume><fpage>225</fpage><lpage>240</lpage></citation><citation citation-type="display-unstructured">Rockett JC, Patrizio P, Schmid JE et al (2004) Gene expression patterns associated with infertility in humans and rodent models. Mutat Res 549:225&#x02013;240 <pub-id pub-id-type="pmid">15120973</pub-id></citation></ref><ref id="CR28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>AW</given-names></name><name><surname>Thornton</surname><given-names>JM</given-names></name><name><surname>Brophy</surname><given-names>K</given-names></name><etal/></person-group><article-title>Chromosome 5q candidate genes in coeliac disease: genetic variation at IL4, IL5, IL9, IL13, IL17B and NR3C1</article-title><source>Tissue Antigens</source><year>2005</year><volume>65</volume><fpage>150</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1111/j.1399-0039.2005.00354.x</pub-id></citation><citation citation-type="display-unstructured">Ryan AW, Thornton JM, Brophy K et al (2005) Chromosome 5q candidate genes in coeliac disease: genetic variation at IL4, IL5, IL9, IL13, IL17B and NR3C1. Tissue Antigens 65:150&#x02013;155 <pub-id pub-id-type="pmid">15713213</pub-id></citation></ref><ref id="CR29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>S</given-names></name><name><surname>Rosenstiel</surname><given-names>P</given-names></name><name><surname>Albrecht</surname><given-names>M</given-names></name><etal/></person-group><article-title>Genetics of Crohn disease, an archetypal inflammatory barrier disease</article-title><source>Nat Rev Genet</source><year>2005</year><volume>6</volume><fpage>376</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1038/nrg1607</pub-id></citation><citation citation-type="display-unstructured">Schreiber S, Rosenstiel P, Albrecht M et al (2005) Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 6:376&#x02013;388 <pub-id pub-id-type="pmid">15861209</pub-id></citation></ref><ref id="CR30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sollid</surname><given-names>LM</given-names></name></person-group><article-title>Coeliac disease: dissecting a complex inflammatory disorder</article-title><source>Nat Rev Immunol</source><year>2002</year><volume>2</volume><fpage>647</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1038/nri885</pub-id></citation><citation citation-type="display-unstructured">Sollid LM (2002) Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2:647&#x02013;655 <pub-id pub-id-type="pmid">12209133</pub-id></citation></ref><ref id="CR32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tjellstrom</surname><given-names>B</given-names></name><name><surname>Stenhammar</surname><given-names>L</given-names></name><name><surname>Hogberg</surname><given-names>L</given-names></name><etal/></person-group><article-title>Gut microflora associated characteristics in children with celiac disease</article-title><source>Am J Gastroenterol</source><year>2005</year><volume>100</volume><fpage>2784</fpage><lpage>2788</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2005.00313.x</pub-id></citation><citation citation-type="display-unstructured">Tjellstrom B, Stenhammar L, Hogberg L et al (2005) Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol 100:2784&#x02013;2788 <pub-id pub-id-type="pmid">16393236</pub-id></citation></ref><ref id="CR31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tlaskalova-Hogenova</surname><given-names>H</given-names></name><name><surname>Stepankova</surname><given-names>R</given-names></name><name><surname>Hudcovic</surname><given-names>T</given-names></name><etal/></person-group><article-title>Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases</article-title><source>Immunol Lett</source><year>2004</year><volume>93</volume><fpage>97</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2004.02.005</pub-id></citation><citation citation-type="display-unstructured">Tlaskalova-Hogenova H, Stepankova R, Hudcovic T et al (2004) Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93:97&#x02013;108 <pub-id pub-id-type="pmid">15158604</pub-id></citation></ref><ref id="CR33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belzen</surname><given-names>MJ</given-names></name><name><surname>Meijer</surname><given-names>JW</given-names></name><name><surname>Sandkuijl</surname><given-names>LA</given-names></name><etal/></person-group><article-title>A major non-HLA locus in celiac disease maps to chromosome 19</article-title><source>Gastroenterology</source><year>2003</year><volume>125</volume><fpage>1032</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1016/S0016-5085(03)01205-8</pub-id></citation><citation citation-type="display-unstructured">van Belzen MJ, Meijer JW, Sandkuijl LA et al (2003) A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology 125:1032&#x02013;1041 <pub-id pub-id-type="pmid">14517787</pub-id></citation></ref><ref id="CR34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belzen</surname><given-names>MJ</given-names></name><name><surname>Vrolijk</surname><given-names>MM</given-names></name><name><surname>Meijer</surname><given-names>JW</given-names></name><etal/></person-group><article-title>A genomewide screen in a four-generation Dutch family with celiac disease: evidence for linkage to chromosomes 6 and 9</article-title><source>Am J Gastroenterol</source><year>2004</year><volume>99</volume><fpage>466</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2004.04072.x</pub-id></citation><citation citation-type="display-unstructured">van Belzen MJ, Vrolijk MM, Meijer JW et al (2004) A genomewide screen in a four-generation Dutch family with celiac disease: evidence for linkage to chromosomes 6 and 9. Am J Gastroenterol 99:466&#x02013;471 <pub-id pub-id-type="pmid">15056087</pub-id></citation></ref><ref id="CR35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heel</surname><given-names>DA</given-names></name><name><surname>Hunt</surname><given-names>K</given-names></name><name><surname>Greco</surname><given-names>L</given-names></name><etal/></person-group><article-title>Genetics in coeliac disease</article-title><source>Best Pract Res Clin Gastroenterol</source><year>2005</year><volume>19</volume><fpage>323</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.bpg.2005.01.001</pub-id></citation><citation citation-type="display-unstructured">van Heel DA, Hunt K, Greco L et al (2005) Genetics in coeliac disease. Best Pract Res Clin Gastroenterol 19:323&#x02013;339 <pub-id pub-id-type="pmid">15925839</pub-id></citation></ref><ref id="CR36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wapenaar</surname><given-names>MC</given-names></name><name><surname>Belzen</surname><given-names>MJ</given-names></name><name><surname>Fransen</surname><given-names>JH</given-names></name><etal/></person-group><article-title>The interferon gamma gene in celiac disease: augmented expression correlates with tissue damage but no evidence for genetic susceptibility</article-title><source>J Autoimmun</source><year>2004</year><volume>23</volume><fpage>183</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2004.05.004</pub-id></citation><citation citation-type="display-unstructured">Wapenaar MC, van Belzen MJ, Fransen JH et al (2004) The interferon gamma gene in celiac disease: augmented expression correlates with tissue damage but no evidence for genetic susceptibility. J Autoimmun 23:183&#x02013;190 <pub-id pub-id-type="pmid">15324937</pub-id></citation></ref></ref-list><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (doi:10.1007/s00251-007-0199-5) contains supplementary material, which is available to authorized users.</p></fn></fn-group></back></article> 